Daliresp vs Advair Diskus
A side-by-side look at two respiratory medications advertised on TV. Informational only — not medical advice.
| US Daliresp | US Advair Diskus | |
|---|---|---|
| Generic name | roflumilast | fluticasone/salmeterol |
| Drug class | PDE4 Inhibitor (Oral) | Inhaled Corticosteroid / LABA Combination |
| Treats | Chronic obstructive pulmonary disease (COPD) | Asthma and COPD |
| Category | Respiratory | Respiratory |
| Manufacturer | AstraZeneca | GSK |
| Year approved | 2011 | 2000 |
| FDA warning | Moderate warnings | Moderate warnings |
| Est. TV ad spend | — | — |
| Common side effects | Diarrhea, Weight loss, Nausea, Headache | Thrush (mouth infection), Hoarse voice, Headache, Throat irritation |
Advair Diskus
Frequently asked questions
Is Daliresp or Advair Diskus better?
Neither is universally "better." Daliresp (roflumilast) and Advair Diskus (fluticasone/salmeterol) are both used for respiratory, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Daliresp and Advair Diskus?
Daliresp is a PDE4 Inhibitor (Oral) made by AstraZeneca, while Advair Diskus is a Inhaled Corticosteroid / LABA Combination made by GSK. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Daliresp has the larger estimated TV advertising budget of the two.